Option Care Health, Inc. (NASDAQ:OPCH – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $22.20 and last traded at $22.28, with a volume of 747109 shares trading hands. The stock had previously closed at $22.85.
Analyst Upgrades and Downgrades
A number of research analysts have issued reports on the stock. Truist Financial reduced their target price on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Barrington Research cut their price target on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a report on Thursday, October 31st. Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and decreased their price target for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. JMP Securities raised their price objective on Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research note on Monday, September 30th. Finally, Bank of America cut Option Care Health from a “buy” rating to a “neutral” rating and cut their target price for the company from $43.00 to $29.00 in a research note on Wednesday, October 30th. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $30.83.
Read Our Latest Analysis on Option Care Health
Option Care Health Stock Down 2.9 %
Insider Buying and Selling at Option Care Health
In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the sale, the director now directly owns 21,339 shares in the company, valued at $663,429.51. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the sale, the director now directly owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Michael H. Shapiro sold 23,217 shares of the business’s stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the sale, the chief financial officer now owns 247,317 shares in the company, valued at $7,654,461.15. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.64% of the company’s stock.
Hedge Funds Weigh In On Option Care Health
Several institutional investors and hedge funds have recently bought and sold shares of the company. FMR LLC increased its holdings in shares of Option Care Health by 134.0% in the third quarter. FMR LLC now owns 7,516,448 shares of the company’s stock worth $235,265,000 after buying an additional 4,304,896 shares during the period. Westfield Capital Management Co. LP raised its stake in Option Care Health by 10.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock valued at $203,204,000 after buying an additional 599,589 shares during the last quarter. Thrivent Financial for Lutherans raised its stake in Option Care Health by 7.4% during the 3rd quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company’s stock valued at $183,541,000 after buying an additional 404,811 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in Option Care Health by 6.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,605,271 shares of the company’s stock valued at $99,870,000 after buying an additional 218,844 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA raised its stake in Option Care Health by 2.6% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 2,518,923 shares of the company’s stock valued at $78,842,000 after buying an additional 63,955 shares during the last quarter. 98.05% of the stock is owned by institutional investors.
Option Care Health Company Profile
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
- Five stocks we like better than Option Care Health
- What Do S&P 500 Stocks Tell Investors About the Market?
- Rocket Lab is the Right Stock for the Right Time
- What Are the FAANG Stocks and Are They Good Investments?
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.